4.7 Review

Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2

Journal

BIOCONJUGATE CHEMISTRY
Volume 31, Issue 9, Pages 2021-2045

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.bioconjchem.0c00323

Keywords

-

Funding

  1. National Institute of Health of United States of America [R01 CA210192, R01 CA206069, R01 CA204552]
  2. Faculty Start up fund from UTRGV
  3. Herb Kosten Foundation
  4. IIT Bombay Healthcare Initiative

Ask authors/readers for more resources

The coronavirus disease 2019 (COVID-19) has dramatically challenged the healthcare system of almost all countries. The authorities are struggling to minimize the mortality along with ameliorating the economic downturn. Unfortunately, until now, there has been no promising medicine or vaccine available. Herein, we deliver perspectives of nanotechnology for increasing the specificity and sensitivity of current interventional platforms toward the urgent need of quickly deployable solutions. This review summarizes the recent involvement of nanotechnology from the development of a biosensor to fabrication of a multifunctional nanohybrid system for respiratory and deadly viruses, along with the recent interventions and current understanding about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available